Smith, B J; Bickel, W K (2001) Effects of alprazolam, caffeine, and zolpidem in humans trained to discriminate triazolam from placebo. Drug Alcohol Depend 61:249-60
|
Smith, B J; Bickel, W K (1999) Comparing single and cumulative dosing procedures in human triazolam discriminators. J Exp Anal Behav 71:417-37
|
Smith, B J; Bickel, W K (1999) The novel-response procedure in humans. Pharmacol Biochem Behav 64:245-50
|
Smith, B J; Bickel, W K (1999) Flumazenil discrimination by humans under a two-response and a novel-response procedure. J Pharmacol Exp Ther 291:1257-68
|
Oliveto, A H; Bickel, W K; Hughes, J R et al. (1997) Functional antagonism of the caffeine-discriminative stimulus by triazolam in humans. Behav Pharmacol 8:124-38
|
Kamien, J B; Bickel, W K; Smith, B J et al. (1997) Secobarbital in humans discriminating triazolam under two-response and novel-response procedures. Pharmacol Biochem Behav 58:983-91
|
Oliveto, A H; Bickel, W K; Kamien, J B et al. (1994) Effects of diazepam and hydromorphone in triazolam-trained humans under a novel-response drug discrimination procedure. Psychopharmacology (Berl) 114:417-23
|
Kamien, J B; Bickel, W K; Hughes, J R et al. (1993) Drug discrimination by humans compared to nonhumans: current status and future directions. Psychopharmacology (Berl) 111:259-70
|
Rush, C R; Higgins, S T; Hughes, J R et al. (1993) A comparison of the acute behavioral effects of triazolam and temazepam in normal volunteers. Psychopharmacology (Berl) 112:407-14
|
Bickel, W K; Oliveto, A H; Kamien, J B et al. (1993) A novel-response procedure enhances the selectivity and sensitivity of a triazolam discrimination in humans. J Pharmacol Exp Ther 264:360-7
|
Showing the most recent 10 out of 13 publications